Deskripsyon CAS: 625115-55-1|Riociguat
| Nimewo CAS | 625115-55-1 |
| Fòmil molekilè | C20H19FN8O2 |
| Pwa molekilè | 422.42 |
| Pite | 98% |
| Pake | 10mg 1g 5g 25g 1kg 10kg 100kg |
Sinonim:
BAY 63-2521;
Riociguat (JAN/INN);
N-[4,6-Diamino-2-[1-[({2-fluorofenil)metil]-1H-pyrazolo[3,4-b ]piridin-3-il]-5-pirimidinil]-N-methylcarbamic asid methyl ester;
Adempas;
Riociguat;
Methyl N-(4,6-diamino-2-{{1-(({2-fluorophenyl)methyl)-1H-pyrazolo (3,4- b)piridin-3-il}pirimidin-5-il)-N-methylcarbamate;
UNI-RU3FE2Y4XI;
metil N-[4,6-diamino-2-[1-[({2-fluorofenil)metil]pirazolo[3,4-b]piridin{{8} }il]pirimidin-5-il]-N-metilkarbamat;
Aplikasyon:
Riociguat (non komès Adempas) se yon dwòg roman (pa Bayer) ki se yon stimulateur nan idrosolubl guanylate cyclase (sGC). Esè klinik yo te gade riociguat kòm yon nouvo apwòch pou trete de fòm tansyon wo nan poumon (PH): tansyon wo poumon tronboembolic kwonik (CTEPH) ak tansyon wo atè poumon (PAH). Riociguat konstitye premye dwòg nan yon klas roman stimulateurs sGC.


Baj popilè: cas: 625115-55-1|riociguat, Lachin cas: 625115-55-1|riociguat manifakti yo, faktori











